Wienhold Romy, Scholz Markus, Adler J Rgen-Bernhard, G Nster Christian, Paschke Ralf
Division of Nephrology-Department of Internal Medicine, Neurology and Dermatology, Universitäts - medizin Leipzig, Wissenschaftliches Institut der AOK (WIdO, AOK's Scientific Institute), Institute for Medical Informatics, Statistics and Epidemiology (IMISE), University of Leipzig.
Dtsch Arztebl Int. 2013 Dec 6;110(49):827-34. doi: 10.3238/arztebl.2013.0827.
In Germany, about 59 000 thyroid operations are performed each year for uni- or multinodular goiter, most of them for diagnostic purposes. The rate of detection of thyroid cancer in such operations is relatively low, at 1:15. Evidence suggests that the preoperative tests recommended in guidelines for estimating the risk of cancer are not being performed as often as they should. In the present study, we determined the measures that were actually taken to diagnose and treat thyroid nodules and compared the findings with the guideline recommendations.
We retrospectively analyzed data from a single, large statutory healthinsurance carrier in Germany (AOK), determining the diagnostic and therapeutic measures that were reimbursed for 25 600 patients in whom a uni- or multinodular goiter was newly diagnosed in the second quarter of 2006 (none of these patients had carried such a diagnosis 1 year previously). We recorded the diagnostic measures performed in the preceding 9 months and all other tests and treatments, including surgery and radioactive iodine treatment, in the 2 years thereafter.
Among patients who underwent surgery for uninodular goiter, the preoperative diagnostic studies included ultrasonography (in 100% of patients), scintigraphy (94%), measurement of thyroid-stimulating hormone (95%), measurement of calcitonin (9%), and fine-needle aspiration cytology (FNAC)(21%). An ultrasonographic examination was billed for only 28% of patients with uninodular goiter in the two years after the diagnosis was made. 13% of patients with uninodular goiter who were not operated on were given L-thyroxine, even though this is against guideline recommendations.
Inadequate preoperative risk stratification of thyroid nodules may explain the large number of thyroid operations that are performed for diagnostic purposes, resulting in a low percentage of malignancies detected. Preoperative FNAC and calcitonin measurement should be used in the diagnostic evaluation of thyroid nodules far more often than this is now done. As a rule, follow-up ultrasonography should be performed for all thyroid nodules that are not operated on. Patients with non-operated thyroid nodules should not be given thyroxine. A limitation of this study is that diagnostic measures were only recorded if they were performed in the 9 months before surgery, with earlier diagnostic measures (if any) being missed.
在德国,每年约有59000例因单发性或多发性甲状腺肿而进行的甲状腺手术,其中大多数是出于诊断目的。此类手术中甲状腺癌的检出率相对较低,为1:15。有证据表明,指南中推荐的用于评估癌症风险的术前检查并未得到应有的频繁执行。在本研究中,我们确定了实际用于诊断和治疗甲状腺结节的措施,并将结果与指南建议进行了比较。
我们回顾性分析了德国一家大型法定健康保险公司(AOK)的数据,确定了2006年第二季度新诊断为单发性或多发性甲状腺肿的25600例患者(这些患者在1年前均未被诊断为此病)所报销的诊断和治疗措施。我们记录了前9个月内进行的诊断措施以及此后2年内的所有其他检查和治疗,包括手术和放射性碘治疗。
在因单发性甲状腺肿接受手术的患者中,术前诊断性研究包括超声检查(100%的患者)、闪烁扫描(94%)、促甲状腺激素测量(95%)、降钙素测量(9%)和细针穿刺活检(FNAC)(21%)。在诊断后两年内,仅有28%的单发性甲状腺肿患者进行了超声检查计费。13%未接受手术的单发性甲状腺肿患者接受了左旋甲状腺素治疗,尽管这与指南建议相悖。
甲状腺结节术前风险分层不足可能解释了大量出于诊断目的而进行的甲状腺手术,导致恶性肿瘤检出率较低。术前FNAC和降钙素测量在甲状腺结节的诊断评估中应比目前更频繁地使用。通常,应对所有未接受手术的甲状腺结节进行随访超声检查。未接受手术的甲状腺结节患者不应给予甲状腺素。本研究的一个局限性是,仅记录了手术前9个月内进行的诊断措施,遗漏了更早的诊断措施(如有)。